RxDoctor Payments Data

Emily Harris

Family · Montgomery, ALNPI 1528467701

Payments from drug & device makers

$2,094in general payments, 2019–2025

Across 112 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$252
  • Novo Nordisk$241
  • Amarin Pharma, Inc.$196
  • GSK$185
  • Amgen$158
  • AbbVie$148
  • plus $912 from 19 others

What the payments were for

  • Food & beverage$2,00096%
  • Education$944%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,094 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$5,848
Medicare patients
38
Services billed
117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide16$16,673
JardianceEmpagliflozin19$16,558
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$11,149
FarxigaDapagliflozin Propanediol11$9,314
Pravastatin Sodium19$452
Chlorthalidone14$377
Amlodipine Besylate48$369
Fluticasone Propionate15$309
Levothyroxine Sodium28$285
Albuterol Sulfate HfaAlbuterol Sulfate16$278
Losartan Potassium25$266
Atorvastatin Calcium24$242
Sertraline Hcl14$229
Carvedilol13$228
Lisinopril22$203

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$90$16,67316 claims
Boehringer IngelheimJardiance$114$16,55819 claims
GSKTrelegy Ellipta$185$11,14913 claims
AstraZenecaFarxiga$111$9,31411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.

Other family in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →